Инвестировать в Швейцарию Ключевые отрасли Предприятия различных отраслей экономики различаются своими потребностями в содействии экспорту и предъявляют собственные требования к месту разм...
Actualités 25.01.2022 Zurich, Genève et Bâle font partie des 10 villes les plus agréables à vivre au monde Les villes suisses continuent à recevoir des notes élevées en ce qui concerne la qualité de vie des expatriés. Selon le nouveau classement sur la...
News 04.07.2023 Top Stories from Western Switzerland (April-June 2023) From space exploration to medical breakthroughs and advancements in education and industry, discover Western Switzerland's top stories from April...
News 28.06.2023 Clear Solutions Labs seeks to benefit from the Basel Area The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science and an...
News 08.03.2023 Bachem receives order totaling more than 500 million Swiss francs Bachem has signed a long-term cooperation agreement for the development and production of peptides. It includes a binding order volume of more th...
News 22.06.2023 MSD opens new research laboratory in Schachen MSD Merck Sharp & Dohme (MSD) has opened a new research laboratory at its site in Schachen in the canton of Lucerne. MSD has invested 20 million ...
News 26.04.2023 Western Switzerland’s biotech sector flourishes amidst global challenges Western Switzerland's biotech industry continues to thrive, displaying resilience amidst global challenges. The region's unique ecosystem fosters...
Aktuell 13.03.2024 PSI entwickelt neue Krebstherapie Forschende des Paul Scherrer Instituts (PSI) haben ein Radiopharmakon gegen metastasierende neuroendokrine Tumore entwickelt. Mit der erstmaligen...
News 05.05.2023 Alentis raises 105 million US dollars Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in the phase I and II programs for...
News 12.06.2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
Actualités 11.05.2022 CEIDOS et Limula reçoivent EUR 1.14 million d’Eurostars pour un dispositif innovant En collaboration avec Limula, la société valaisanne CEIDOS a reçu une bourse de EUR 1,14 million d'Eurostars pour développer un dispositif dédié ...
最新 25.01.2022 苏黎世、日内瓦和巴塞尔位居全球生活质量最高的十佳城市之列 从外籍人士的生活质量来看,瑞士的城市在该方面始终名列前茅。根据国际咨询公司美世咨询(Mercer)最新发布的全球生活质量排名,日内瓦、苏黎世和巴塞尔均排在该榜单的前十位。
News 29.03.2023 Western Switzerland’s sustainability innovators making global impact Western Switzerland is home to a range of sustainability start-ups that are making waves on the international stage.
News 29.03.2023 Alithea Genomics secures CHF 500,000 to boost RNA sequencing technology Alithea Genomics has secured a CHF 500,000 Tech Growth loan from the FIT to launch two new products and expand its RNA sequencing technology port...
News 11.01.2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 08.03.2022 Le site technologique de BioArk Monthey s’agrandit Suite à une première extension en 2015, le site technologique spécialisé dans les sciences de la vie, BioArk Monthey, s’agrandit à nouveau et acc...
Talent 29.06.2023 Find Talent Are you looking for skilled personnel in the Life Science industry? Switzerland is famous for its highly qualified workforce. Find out how your L...
Research and Development 11.07.2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...